Abstract
Aim. To determine the incidence of recurrent nevus after removal of benign melanocytic nevi and to evaluate the influence of clinical, dermoscopic, morphological, and treatment-related factors on recurrence risk.
Materials and methods. A retrospective single-center analytical study with passive follow-up was conducted. A total of 339 cases of benign melanocytic nevi removed between May 2020 and May 2025 were included. The mean patient age was 36.7±11.9 years; 234 patients (69.0%) were female and 105 (31.0%) were male. Sex, age, lesion localization, diameter, dermoscopic characteristics, histological subtype, treatment method, and recurrence rate were analyzed. Statistical analysis was performed using Pearson’s χ² test and Student’s t-test.
Results. Recurrent nevus was identified in 45 of 339 cases (13.3%). The mean time to recurrence was 5.24±1.05 months. Patients with recurrence were significantly younger than those without recurrence (29.89±13.46 years vs. 37.71±11.27 years; p=0.00005). No statistically significant associations were found between recurrence and sex, lesion localization, lesion diameter, dermoscopic pattern, histological subtype, structural organization, or treatment method (p>0.05).
Conclusions. The incidence of recurrent nevus after removal of benign melanocytic nevi was 13.3%. Most recurrences developed within six months after treatment. Younger age was the only statistically significant factor associated with recurrence.
References
Swetter, S. M., Tsao, H., Bichakjian, C. K., Curiel-Lewandrowski, C., Elder, D. E., Gershenwald, J. E., et al. (2019). Guidelines of care for the management of primary cutaneous melanoma. Journal of the American Academy of Dermatology, 80(1), 208–250. https://doi.org/10.1016/j.jaad.2018.08.055
Leiter, U., Keim, U., & Garbe, C. (2020). Epidemiology of skin cancer: Update 2019. Advances in Experimental Medicine and Biology, 1268, 123–139. https://doi.org/10.1007/978-3-030-46227-7_6
Korovin, S., Fedorenko, Z., Michailovich, Y., Kukushkina, M., Sekerija, M., & Ryzhov, A. (2020). Burden of malignant melanoma in Ukraine in 2002–2013: Incidence, mortality and survival. Experimental Oncology, 42(4), 324–329. https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-4.15334
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 74(3), 229–263. https://doi.org/10.3322/caac.21834
Dinnes, J., Deeks, J. J., Chuchu, N., Ferrante di Ruffano, L., Matin, R. N., Thomson, D. R., et al. (2018). Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults. Cochrane Database of Systematic Reviews, (12), CD011902. https://doi.org/10.1002/14651858.CD011902.pub2
Williams, N. M., Marchetti, M. A., Dusza, S. W., et al. (2021). Assessment of diagnostic accuracy of dermoscopic structures and patterns used in melanoma detection: A systematic review and meta-analysis. JAMA Dermatology, 157(9), 1078–1088. https://doi.org/10.1001/jamadermatol.2021.2845
Briatico, G., Brancaccio, G., Scharf, C., Moscarella, E., Di Brizzi, E. V., Balato, A., & Argenziano, G. (2024). Indications for and contraindications to digital monitoring of patients with melanocytic lesions. Dermatology Practical & Conceptual, 14(3), e2024200. https://doi.org/10.5826/dpc.1403a200
Jurakić Tončić, R., Vasari, L., Štulhofer Buzina, D., Ledić Drvar, D., Petković, M., & Čeović, R. (2024). The role of digital dermoscopy and follow-up in the detection of amelanotic/hypomelanotic melanoma in a group of high-risk patients—is it useful? Life, 14(9), 1200. https://doi.org/10.3390/life14091200
Torbenko, Y., & Litus, V. (2026). Clinico-dermoscopic and histopathological correlations of benign melanocytic nevi of the skin as a basis for the choice of treatment and recurrence prevention (literature review). Medical Perspectives, 31(1), 35–48. https://doi.org/10.26641/2307-0404.2026.1.356818
Araghi, F., Ohadi, L., Moravvej, H., Amani, M., Allameh, F., & Dadkhahfar, S. (2022). Laser treatment of benign melanocytic lesion: A review. Lasers in Medical Science, 37(9), 3353–3362. https://doi.org/10.1007/s10103-022-03642-9
Goodson, A. G., Florell, S. R., Boucher, K. M., & Grossman, D. (2010). Low rates of clinical recurrence after biopsy of benign to moderately dysplastic melanocytic nevi. Journal of the American Academy of Dermatology, 62(4), 591–596. https://doi.org/10.1016/j.jaad.2009.06.080
Maghari, A., Schwartz, M. R., & Tschen, J. A. (2016). Recurrence of dysplastic nevi is strongly associated with extension of the lesions to the lateral margins and into the deep margins through hair follicles in the original shave removal specimens. Dermatology Research and Practice, 2016, 7310856. https://doi.org/10.1155/2016/8523947
Heck, R., Ferrari, T., Cartell, A., & Bakos, R. M. (2019). Clinical and dermoscopic (in vivo and ex vivo) predictors of recurrent nevi. European Journal of Dermatology, 29(2), 179–184. https://doi.org/10.1684/ejd.2019.3530
Castagna, R. D., Stramari, J. M., & Chemello, R. M. L. (2017). The recurrent nevus phenomenon. Anais Brasileiros de Dermatologia, 92(4), 531–533. https://doi.org/10.1590/abd1806-4841.20176190
Blum, A., Hofmann-Wellenhof, R., Marghoob, A. A., Argenziano, G., Cabo, H., Carrera, C., et al. (2014). Recurrent melanocytic nevi and melanomas in dermoscopy: Results of a multicenter study of the International Dermoscopy Society. JAMA Dermatology, 150(2), 138–145. https://doi.org/10.1001/jamadermatol.2013.6908
King, R., Hayzen, B. A., Page, R. N., Googe, P. B., Zeagler, D., & Mihm, M. C. Jr. (2009). Recurrent nevus phenomenon: A clinicopathologic study of 357 cases and histologic comparison with melanoma with regression. Modern Pathology, 22(5), 611–617. https://doi.org/10.1038/modpathol.2009.22.
Kucharik, A. H., Ghali, H., Milani, D., Warbasse, E., Li, P., Ravichandran, S., et al. (2025). PRAME expression in recurrent/persistent melanocytic nevi. American Journal of Dermatopathology, 47(11), 834–839. https://doi.org/10.1097/DAD.0000000000003104
Carraturo, E., D’Abbronzo, G., Argenziano, G., Brancaccio, G., Scharf, C., Moscarella, E., et al. (2025). PRAME immunohistochemical expression in recurrent/traumatized melanocytic nevi and the pitfall of expression by reactive fibroblasts. Dermatology Practical & Conceptual, 15(4), 5564. https://doi.org/10.5826/dpc.1504a5564
Camini, L., Manzoni, A. P. D., Weber, M. B., Luzzatto, L., Soares, A. S., & Bonamigo, R. R. (2021). Shave excision versus elliptical excision of nonpigmented intradermal melanocytic nevi: Comparative assessment of recurrence and cosmetic outcomes. Dermatologic Surgery, 47(2), e21–e25. https://doi.org/10.1097/DSS.0000000000002666
Fedorenko, Z. P., Michailovich, Y. Y., Gulak, L. O., et al. (2025). Cancer in Ukraine, 2023–2024: Incidence, mortality, activities of oncological service (Bulletin of the National Cancer Registry of Ukraine, No. 26). National Cancer Registry of Ukraine. http://www.ncru.inf.ua/publications/BULL_26/PDF_E/0-titul.pdf

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

